Cervical Cancer Treatment Market Size, Share and Forecast 2026
The Cervical Cancer Treatment Market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of XX% during the forecast period.
(EMAILWIRE.COM, September 13, 2019 ) Market Overview:
Cervix is the lower part of the uterus that connects to vagina. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted infection, is responsible for 90% of cervical cancers. There are more than 100 strains of HPV, out of which 13 are high-risk or cancerous. Other factors include, oral contraceptives, multiple sexual partners, smoking, and HIV infection.
Market Dynamics:
The market is driven by increased prevalence of cervical cancer, proactive government initiatives, awareness among people, new advancements in targeted therapies and strong pipeline of drugs. High cost of treatment and adverse effects associated with cancer therapy, less number of targeted drugs with improved clinical profile at reduced costs and lack of awareness of cancer treatment in developing countries are going to restrain the market in the forecast period.
Market Segmentation:
By Type of Cancer
• Squamous Cell Carcinoma
• Adenocarcinoma
• Adenosquamous Carcinoma
By Treatment
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Combined Therapy
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• F. Hoffmann-LA Roche AG*
• Merck & Co., Inc.
• GlaxoSmithKline PLC
• Allergan PLC
• Pfizer, Inc.
• Biocon Ltd.
• Others
View full report: https://www.datamintelligence.com/research-report/cervical-cancer-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/cervical-cancer-treatment-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Cervix is the lower part of the uterus that connects to vagina. Cervical cancer develops in the cells of the cervix. Strains of Human Papillomavirus (HPV), a sexually transmitted infection, is responsible for 90% of cervical cancers. There are more than 100 strains of HPV, out of which 13 are high-risk or cancerous. Other factors include, oral contraceptives, multiple sexual partners, smoking, and HIV infection.
Market Dynamics:
The market is driven by increased prevalence of cervical cancer, proactive government initiatives, awareness among people, new advancements in targeted therapies and strong pipeline of drugs. High cost of treatment and adverse effects associated with cancer therapy, less number of targeted drugs with improved clinical profile at reduced costs and lack of awareness of cancer treatment in developing countries are going to restrain the market in the forecast period.
Market Segmentation:
By Type of Cancer
• Squamous Cell Carcinoma
• Adenocarcinoma
• Adenosquamous Carcinoma
By Treatment
• Surgery
• Radiation Therapy
• Chemotherapy
• Targeted Therapy
• Immunotherapy
• Combined Therapy
Geographical Analysis:
By Geography, the market is segmented into:
• North America
• Europe
• South America
• Asia Pacific
• The Middle East and Africa
Competitive Analysis:
Key Players:
• F. Hoffmann-LA Roche AG*
• Merck & Co., Inc.
• GlaxoSmithKline PLC
• Allergan PLC
• Pfizer, Inc.
• Biocon Ltd.
• Others
View full report: https://www.datamintelligence.com/research-report/cervical-cancer-treatment-market
Download free sample: https://www.datamintelligence.com/download-sample/cervical-cancer-treatment-market
About Us:
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information:
Sai Kiran
Sales Manager at Data M Intelligence
Email: info@datamintelligence.com
Tel: +1 877 441 4866
Website: www.datamintelligence.com
Contact Information:
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
DataM Intelligence
Sai Kiran
Tel: +1 877 441 4866
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results